CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 4 Shares withheld for taxes Chief Accounting Officer gave up 785 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 62,000 shares at $13.13 ($814,196)
- 4 Open-market buy 10% owner bought 15,000 shares at an average $13.05 ($195,681)
- 4 Open-market buy 10% owner bought 200,000 shares at an average $13.04 ($2,608,707)
- 4 Grant or award Director acquired 16,495 shares (grant or award)
- 4 Grant or award Director acquired 16,495 shares (grant or award)
- 4 Grant or award Director acquired 16,495 shares (grant or award)
- 4 Grant or award Director acquired 16,495 shares (grant or award)
- 4 Grant or award Director acquired 16,495 shares (grant or award)
- 4 Grant or award Director acquired 16,495 shares (grant or award)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 784 shares (to pay taxes)
- 4/A Open-market buy 10% owner bought 96,000 shares at an average $13.22 ($1,269,375)
- 4 Open-market buy 10% owner bought 60,000 shares at an average $13.07 ($784,228)
- 4 Open-market buy 10% owner bought 290,000 shares at $12.34 ($3,577,411)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Accounting Officer acquired 14,344 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $10.87 ($32,603)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,852 shares (to pay taxes)
Page 4 of 39 · 776 filings